# Efficacy and Safety of GENOSS SES in Patients With Coronary Artery Disease

> **NCT06841510** · — · ACTIVE_NOT_RECRUITING · sponsor: **Genoss Co., Ltd.** · enrollment: 1118 (actual)

## Conditions studied

- Coronary Arterial Disease (CAD)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06841510
- **Lead sponsor:** Genoss Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-04-19
- **Primary completion:** 2025-11-30
- **Final completion:** 2025-11-30
- **Target enrollment:** 1118 (ACTUAL)
- **Last updated:** 2025-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06841510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06841510, "Efficacy and Safety of GENOSS SES in Patients With Coronary Artery Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06841510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*